How many investments has P53 Invest made?

P53 Invest has 12 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.

What stage does P53 Invest invest at?

P53 Invest invests at the Series A stage.

Where is P53 Invest located?

P53 Invest is headquartered in Stavanger, NO.

Who does P53 Invest co-invest with?

P53 Invest most often shares deals with Catalio Capital Management, LP, Gaingels, Manta International Consultancy S.A.L, among 32 tracked co-investors.

P53 Invest

Venture capital

Stavanger · Series A · 5 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into P53 Invest

Paths you didn't know you had: your email and LinkedIn already hold routes to the P53 Invest team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

p53 Invest focuses on healthcare companies that pursue novel approaches and challenge the status quo. It invests in businesses founded on strong scientific and technological foundations, guided by a belief in long-term value creation. The firm aims to transform people's lives through groundbreaking ideas within the healthcare sector.

Invests inBiotech Digital Health Healthtech Longevity Medical Devices Mental Health Denmark Europe Germany North America Norway Stavanger Switzerland

Source: firm website, verified Sep 27, 2026.

Leave your own feedback

Stage

Series A

Stavanger, NO

Instruments

Equity

Founded

2018

Last 12 months

1 investment

Tracked investments

IPOs

Team · 5 people

from the firm's website & public directories

Susanne Stuffers· CEO & founding partner· Delhi, India

Holds an M.D. from Erasmus University Rotterdam and a Ph.D. in cancer biomedicine from the Norwegian Radiumhospital. She has broad healthcare and life sciences experience as a management consultant at EY, in medical and commercial roles at Novartis, clinical oncology practice, and as a healthcare equity analyst at Arctic Securities before co-founding and leading P53.

susanne@tdveen.no

Lars Mørland Knudsen· Investment Director· Oslo, Oslo, Norwayin

Holds a master's in molecular biology from Oslo University with research at the Norwegian Radiumhospital, where he later worked for several years and contributed to published research. He worked as a healthcare equity research analyst at Arctic Securities before joining P53 Invest.

larsmk@p53.no

Kjell Skappel· Chair of the board

CEO of TD Veen and founding partner of Stavanger Venture AS, an angel-to-venture-phase investment company established with TD Veen in 2010. He previously served as Regional Director Europe North at Cisco Systems and held leadership roles at TANDBERG ASA prior to its acquisition by Cisco.

Øyvind Schanke· Director

Chief Investment Officer at TD Veen with an MBA from NHH and over 25 years of investment experience. He was previously CEO of Skagen Funds and spent nearly 16 years at the Norwegian Sovereign Wealth Fund, latterly as CIO for asset management in London.

Silje Veen· Director

Holds a marketing degree from the Norwegian Business School (BI) specializing in local business development. She founded and ran the food concept Food Story for over a decade and chairs the board of TD Veen.

What they invest in

from 9 of 12 portfolio companies

Biotech ×6Healthtech ×5Medical Devices ×3Deep Tech ×2Longevity ×2Marketing Tech ×2Mental Health ×2AI & Machine Learning ×1

HQs:Norway×4United Kingdom×2Denmark×1United States×1

Investments · 12 tracked

founders shown can be your intro path

By year:2025 · 1 2023 · 12 dated

AtaiBeckleyatai.lifeNASDAQ: ATAI

AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions.

BiotechDeep TechDigital HealthHealthtechMedical DevicesMental Health

Srinivas Rao(Co-Founder and Chief Executive Officer)inChristian Angermayer(Founder and Chairman of the Board)

Co-investorsAble Partners Alpha Wave Global AtaiBeckley Bailey Venture Partners Bright Success Capital Catalio Capital Management, LP +13 more

Teitur Trophicsteiturtrophics.com inMar 2023✓ verified

Teitur Trophics is a biotech company developing therapies that target the sortilin family of receptors (SorCS-receptor biology) to activate the brain's natural survival pathways and preserve brain function.

BiotechDeep TechHealthtechLongevityAarhus, DK

Simon Mølgaard(Co-founder & CEO)inAnders Dalby(Co-founder)inMathias Ollendorff(Co-founder)inSimon Glerup(Co-founder)in

Co-investorsIndustrifonden Innovestor Sound Bioventures Sunstone Capital

Aldenteal-dente.no in

Aldente is a Norwegian agency that co-creates strategy, communication, and solutions with a focus on sustainability.

Impact & Social GoodMarketing Tech

Co-investors500 Global

Calluna Pharmacallunapharma.com in

Completed patient enrollment in its Phase 2 AURORA trial.

Co-investorsSarsia Management AS Forbion Investinor

Centenara Labscentenara.com in 𝕏

Centenara Labs is a longevity-focused drug discovery company that translates research on the biology of aging into therapies intended to improve healthy aging and extend lifespan.

BiotechHealthtechLongevity

Christian Angermayer(Founder)in

Co-investorsCatalio Capital Management, LP Gaingels Korify Capital Manta International Consultancy S.A.L

Kodekskodeks.no in

Kodeks develops custom websites and online stores, combining design, technology, and digital strategy, and builds editor-friendly sites in collaboration with design agencies.

E-commerceMarketing TechSaaS

Nykode Therapeuticsnykode.com in

Nykode Therapeutics is a biotechnology company; this investor relations page provides shareholder information, financial reports, and corporate governance details but does not describe the company's specific products or therapeutic focus.

BiotechHealthtechMedical DevicesOslo, NO

Serenatis Bioserenatisbio.com in

Serenatis Bio develops small-molecule drugs targeting glutamate and dopamine pathways to treat obsessive-compulsive disorder, a mental health condition with limited effective therapeutic options.

BiotechMental HealthCambridge, GB

Nick Sireau(Executive Chairman & Co-founder)in David Cavalla(CEO & Co-founder)in

Co-investorsZinc

Tom Hagatomhaga.no

Tom Haga is a photography and film studio offering commercial imagery across categories including hotels, branding, interiors, products, portraits, food and restaurants, aquaculture, industrial, and cars.

Creator EconomyMedia & Entertainment

Tom Haga

Valink Therapeuticsvalinktx.com inOct 2025

Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.

AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US

Arne Scheu(Founder)in Irsyad Khairil(Founder)in

Co-investorsHoxton Ventures LongeVC Metaplanet Oxonian Ventures RV Invest GmbH SynBioVen +9 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Arxx Therapeuticsatai Life Sciences

Exits · 1

1 IPOs

AtaiBeckleyNASDAQ: ATAI

Portfolio news

latest coverage across their companies

Valink Therapeutics Closes $11.8M Pre-A Financing Round

Valink Therapeutics · finsmes.com · Oct 20, 2025

Frequently asked questions

How many investments has P53 Invest made?: P53 Invest has 12 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
What stage does P53 Invest invest at?: P53 Invest invests at the Series A stage.
What sectors does P53 Invest focus on?: P53 Invest focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Mental Health.
Where is P53 Invest located?: P53 Invest is headquartered in Stavanger, NO.
Who does P53 Invest co-invest with?: P53 Invest most often shares deals with Catalio Capital Management, LP, Gaingels, Manta International Consultancy S.A.L, among 32 tracked co-investors.

Similar investors

GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.

$250K – $50M

JAZZ Venture Partners

JAZZ Venture Partners is a venture capital firm investing in early- and growth-stage companies at the intersection of technology, science, and human performance across enterprise, wellness, healthcare, and consumer markets.

$100K – $20M

LongeVC

LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.

PsyMed Ventures

PsyMed Ventures is an early-stage venture firm investing in neuroscience and frontier technologies aimed at improving brain and mental health.

Noetic

Noetic is a venture firm investing in early-stage technologies addressing mental health and wellbeing, spanning drug therapeutics, psychedelic-assisted therapies, digital health, medical devices, and wearables.